IND-enabling preclinical development of a multipurpose intravaginal ring for the prevention of herpes, HIV and unintended pregnancy
Ended Project Grant Awarded Last action
- Award ID
- R33AI136008
- Recipient
-
Auritec Pharmaceuticals, LLC UEI QX8KP6JKQ2L8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,767,452
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Funding
-
- $2,306,818.00 Federal
- $460,634.00 Non-federal
- Place of performance
- Pasadena, CA 91107, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $462,000 | $0 | |
| Amendment | $462,000 | $0 | |
| Amendment | $460,634 | $0 | |
| Amendment | $460,634 | $460,634 | |
| Original award | $461,550 | $0 |
Quick answers
Who received award R33AI136008?
R33AI136008 was awarded to Auritec Pharmaceuticals, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2018.
How much is award R33AI136008 worth?
$2,767,452 has been obligated on R33AI136008: $2,306,818 in federal funding and $460,634 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award